Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000196

Director sold 1,727 shares at $23.79 ($41,085)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Krognes Steve E. Director 2024-08-20 Sale −1,727 $23.79 $41,085 32,677 D: show line 1 in the form
Open-market sales · 1,727 sh · avg $23.79 · $41,085
Loading xslF345X05/wk-form4_1724357741.xml…